Stock Message Boards
ETF Channel
Market News Video Self Directed Investor The Warren Buffetts Next Door Stock message boards Portfolio Channel


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
HALO Description — Halozyme Therapeutics Inc

Halozyme Therapeutics is a biopharmaceutical company. Co.'s research focuses on human enzymes that alter the extracellular matrix. The majority of Co.'s approved product and product candidates are based on rHuPH20, its patented recombinant human hyaluronidase enzyme. Co.'s proprietary products include: Hylenex recombinant which facilitates subcutaneous (SC) fluid administration for attaining hydration, to increase the dispersion and absorption of other injected drugs and, in SC urography, to improve resorption of radiopaque agents; Ultrafast Insulin Program for the diabetes market; PEGPH20 for the treatment of tumors; and HTI-501 for the treatment of edematous fibrosclerotic panniculopathy.

Company Name:  Halozyme Therapeutics Inc
Website:  www.halozyme.com
Sector:  Biotechnology
Number of ETFs Holding HALO:  17
Total Market Value Held by ETFs:  $59,440,169
Total Market Capitalization:  $1,085,000,000
% of Market Cap. Held by ETFs:  5.48%
 ETF   HALO Weight   HALO Amount 
 XBI   1.10%   $15,744,669         
 IWM   0.06%   $15,545,039         
 IBB   0.24%   $15,500,348         
 IWO   0.11%   $7,203,541         
 VBK   0.06%   $2,610,497         
 VHT   0.03%   $1,441,402         
 BIB   0.16%   $769,466         
 IWV   0.00%   $280,659         
 UWM   0.05%   $126,990         
 URTY   0.04%   $74,373         
List of all 17 ETFs holding HALO »
10 ETFs With Stocks That Insiders Are Buying
25 Dividend Giants Widely Held By ETFs
25 S.A.F.E. Dividend Stocks Increasing Payments For Decades
Broker Darlings: Top 15 Analyst Picks of the Dow
Top 25 Broker Analyst Picks of the S&P 500
Forgotten S&P 500 Giants: Analysts' Current Least Favorites
25 Top Ranked Socially Responsible Dividend Stocks
10 Oversold ETFs
The Top 10 DividendRank'ed Stocks
The DividendRank Top 25
The Top 10 DividendRank'ed DJIA Components
The Top 10 DividendRank'ed Dow Transports Components
The Top 10 DividendRank'ed Dow Utilities Components
The Top 10 DividendRank'ed Nasdaq 100 Components
10 Stocks Going Ex-Dividend
10 Oversold Dividend Stocks
10 Stocks Where Yields Got More Juicy
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Top Ranked Dividend Stocks With Insider Buying
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Metals Stocks You Can Buy Cheaper Than Insiders Did
10 Oversold Metals Stocks
10 Must-Know High-Yield REITs
10 Top DividendRank'ed Financials
10 Top DividendRank'ed Metals Stocks
10 Oversold Energy Stocks
10 Top DividendRank'ed Energy Stocks
10 Top DividendRank'ed Utility Stocks
10 Stocks Crossing Below Book Value
10 Stocks Crossing Above Their 200 Day Moving Average
10 Stocks Crossing Below Their 200 Day Moving Average
10 ETFs Crossing Above Their 200 DMA
The 10 Biggest ETFs
The 10 Best ETF Performers
The 10 Worst ETF Performers
10 ETFs With Notable Inflows
10 ETFs With Notable Outflows
The Top 10 DividendRank'ed Canadian Stocks
The DividendRank Canada Top 25
10 Canadian Stocks Going Ex-Dividend
10 Oversold Canadian Stocks
10 Canadian Stocks Where Yields Got More Juicy
10 Must-Know High-Yield Canadian Real Estate Stocks
10 Top DividendRank'ed Canadian Financials
10 Must-Know High-Yield Canadian Energy Stocks
10 Canadian Stocks Crossing Below Book Value
10 Canadian Stocks Crossing Above Their 200 Day Moving Avg
10 Canadian Stocks Crossing Below Their 200 Day Moving Avg
Stock market game
Quotes delayed 20 minutes

Buy (3.25 out of 4)
58th percentile
(ranked higher than approx. 58% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite


PARTNER NEWS:

Thu, Dec 18, 5:48 PM, Zacks
Halozyme Up on Collaboration and Licensing Deal with J&J - Analyst Blog
Shares of Halozyme (HALO) jumped after announcing a worldwide collaboration and license agreement with Johnson & Johnson (JNJ).

Thu, Oct 23, 7:18 AM, Zacks
NewLink Genetics Corporation (NLNK) in Focus: Stock Soars 15.4% - Tale of the Tape
NewLink Genetics Corporation (NLNK) was a big mover last session, as the company saw its shares rise by over 15% on the day.

ETFs Holding HALO | Halozyme Therapeutics Inc | ETF Channel | www.ETFChannel.com | Copyright © 2009 - 2014, All Rights Reserved

Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; ETF data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.